Almirall, S.A. (OTCMKTS:LBTSF) Short Interest Down 12.5% in January

Almirall, S.A. (OTCMKTS:LBTSF) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 85,600 shares, a decrease of 12.5% from the December 31st total of 97,800 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Almirall Stock Performance

Shares of LBTSF remained flat at $9.17 during midday trading on Monday. The business has a 50-day moving average of $9.17 and a 200-day moving average of $9.39. Almirall has a 52-week low of $9.17 and a 52-week high of $9.17.

Almirall Company Profile

Almirall, SA, a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.